Related Experiment Videos

Treatment with phenoxybenzamine of upper urinary tract complications caused by intravesical obstruction

The Journal of Urology
|January 1, 1975
PubMed

Insights

Phenoxybenzamine effectively treated persistent reflux and hydronephrosis in children unresponsive to surgery. This alpha-adrenergic blocker improved bladder outlet resistance and intravesical pressure, preventing the need for urinary diversion.

Area of Science:

  • Pediatric Urology
  • Pharmacology

Background:

  • Reflux and hydronephrosis can persist despite surgical interventions in children.
  • Elevated bladder outlet resistance and high intravesical pressure are key findings in refractory cases.

Purpose of the Study:

  • To evaluate the efficacy of phenoxybenzamine in children with persistent reflux and hydronephrosis.
  • To explore the role of alpha-adrenergic blockade in managing complex bladder dysfunction.

Main Methods:

  • Case series of five children with refractory reflux and hydronephrosis.
  • Utilized cystomanometry to assess bladder outlet resistance and intravesical pressure.
  • Administered phenoxybenzamine (an alpha-adrenergic blocker) for treatment.

Main Results:

  • Phenoxybenzamine therapy was successful in all five children.
  • Restored upper urinary tract urine passage and unimpaired voiding.
  • Prevented the need for urinary diversion in all cases.

Conclusions:

  • Phenoxybenzamine is a viable treatment for persistent pediatric reflux and hydronephrosis.
  • Alpha-adrenergic blockade can effectively manage bladder outlet obstruction and high intravesical pressure.
  • Sympathetic hyperfunction may contribute to bladder complications in these cases.

Related Concept Videos